Related Experiment Video
Updated: May 8, 2025

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Clinical Features and Transition of Acute Hepatitis B Virus Infection
Huali Wang1, Jian Wang2,3, Shaoqiu Zhang2
1Department of General Practice, Nanjing Second Hospital, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Insights
Most adults clear acute hepatitis B (AHB) within six months. Lower baseline hepatitis B surface antigen (HBsAg) and higher antibody to hepatitis B core antigen (anti-HBc) predict clearance, identifying patients at risk for chronic infection.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Acute hepatitis B (AHB) is typically self-limiting in adults, with most patients achieving hepatitis B surface antigen (HBsAg) clearance within six months.
- Understanding factors influencing chronic outcomes in AHB is crucial for patient management.
Purpose of the Study:
- To investigate the proportion of adult AHB patients who do not achieve HBsAg clearance within six months.
- To identify factors influencing HBsAg clearance in adult AHB patients.
Main Methods:
- A cohort of 126 adult AHB patients was analyzed retrospectively.
- Multivariate regression analysis was employed to determine factors associated with HBsAg clearance.
Main Results:
- 11.1% of patients did not achieve HBsAg clearance within six months; this reduced to 4.0% after one year.
- Lower baseline HBsAg levels (≤250 IU/mL) and higher antibody to hepatitis B core antigen (anti-HBc) levels were significantly associated with HBsAg clearance.
- Anti-HBc remained an independent predictor of HBsAg clearance across different HBsAg subgroups.
Conclusions:
- Baseline HBsAg and anti-HBc levels can help identify adult AHB patients at risk of developing chronic infection.
- Early identification of at-risk patients allows for targeted monitoring and potential intervention strategies.
Abstract:
Acute hepatitis B (AHB) is generally a self-limiting illness in adults and most patients achieve hepatitis B surface antigen (HBsAg) clearance within 6 months. We aimed to investigate the proportion and influencing factors of chronic outcome in adult AHB patients. A total of 126 consecutive AHB patients were included between January 2013 and October 2018. Multivariate regression analysis was conducted to evaluate the influencing factor of HBsAg clearance. Fourteen (11.1%) patients failed to achieve HBsAg clearance within 6 months. Among them, nine patients achieved HBsAg clearance within 6-12 months, while five patients had persistent HBsAg positive over 1 year. Patients with HBsAg clearance had lower baseline antibody to hepatitis B core antigen (anti-HBc) (7.0 S/CO vs. 8.0 S/CO, p = 0.090) and HBsAg levels than those with chronicity of AHB. Multivariate analysis revealed that HBsAg ≤ 250 IU/mL (HR 3.008, IQR 1.877, 4.820, p < 0.001) and anti-HBc levels (HR 0.830, IQR 0.755, 0.912, p < 0.001) was significantly associated with HBsAg clearance. Anti-HBc remained an independent predictor of HBsAg clearance in different HBsAg subgroups. Patients with HBsAg > 250 IU/mL (p < 0.001) and high anti-HBc (p = 0.001) had lower cumulative HBsAg clearance rates than those with low HBsAg and anti-HBc. 11.1% of AHB patients did not achieve HBsAg clearance within 6 months, while the proportion of patients with persistent HBsAg positive decreased to 4.0% after 1 year. Combination of baseline HBsAg and anti-HBc levels could identify patients who might have a possible risk of chronicity following AHB.
More Related Videos
Related Concept Videos
Stages of Infection
Acute Pancreatitis II: Clinical Manifestations and Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Retrovirus Life Cycles
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

